Chinese researchers have made what they claim is “a historic breakthrough” in the treatment of haemophilia, an inherited disorder that can cause unstoppable bleeding. They designed gene therapy drug BBM-H901 to treat haemophilia B and have found it to be safe and effective in preventing bleeding events a year after infusion. After 58 weeks of treatment, the average level of...